During the past decade, Consultants in Medical Oncology and Hematology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Consultants in Medical Oncology and Hematology" #1 sponsor was "SCRI Development Innovations, LLC" with 5 trials, followed by "Novartis Pharmaceuticals" with 2 trials sponsored, "BeiGene" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Christopher Sweeney, MBBS" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Consultants in Medical Oncology and Hematology" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Consultants in Medical Oncology and Hematology" are "Prostate Cancer" (3 trials), "Cachexia" (1 trials), "Cancer of the Rectum" (1 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials) and "Colonic Neoplasms" (1 trials). Many other conditions were trialed in "Consultants in Medical Oncology and Hematology" in a lesser frequency.

Most popular intervention types in "Consultants in Medical Oncology and Hematology" are "Drug" (14 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Docetaxel" (2 trials), "Gemcitabine" (2 trials), "Placebo" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Consultants in Medical Oncology and Hematology" are 12 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Consultants in Medical Oncology and Hematology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Consultants in Medical Oncology and Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Consultants in Medical Oncology and Hematology, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".